JAKARTA, Indonesia, March 20, 2023 /PRNewswire/ PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. This round of financing will be used for further strengthening the company's pipeline and portfolio especially in Oncology area to be drug substances manufacturing facilities. Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production and technology capability. Currently, Etana focuses on local biopharmaceutical production for mRNA platforms, proteins and monoclonal antibodies. The Inauguration of Etana factory by the President of the Republic Indonesia, Joko Widodo accompanied by by Coordinating Minister for Maritime Affairs and Investment, Luhut Binsar Pandjaitan (right) and President Director of Etana, Nathan Tirtana (left) "Etana as an Indo